Small Caps TodaySmall Caps TodayPharma
12 Articles
Jul 22, 2025
Merck’s $10 Billion Bet On Verona: Smart Strategic Pivot Or Costly Diversion From The Keytruda Cliff?
8 min read8' read
Jul 17, 2025
Eli Lilly’s Obesity Pill Could Be a Game-Changer — But Here’s Why Zepbound Already Has a Giant Lead
8 min read8' read
Jul 03, 2025
Hims & Hers Stock Plunges After Novo Nordisk Breakup: What Really Happened?
7 min read7' read
Jun 25, 2025
Eli Lilly’s $1.3 Billion Gene Editing Bet: What the Verve Deal Signals for the Future of Heart Disease!
8 min read8' read
Mar 25, 2025
ASBP: Unlocking Multi-Billion Dollar Markets with Enhanced Drug Delivery
7 min read7' read
Mar 10, 2025
Aspire Biopharma CEO Interview: Disrupting Drug Delivery with Sublingual Tech
8 min read8' read
NanoViricides Recent Clinical Updates and Milestones Highlight Potential Investor Opportunities
6 min read6' read
TG Therapeutics: Is It Time to Invest In This Biotech Player After The Unprecedented 36.4% Jump?
6 min read6' read
NanoViricides Gets Big Funding Boost From CEO Dr. Anil Diwan Prior To IND Application
5 min read5' read
Discover top 10 categories
Let's explore the most popular categories
Join our newsletter 🎉
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account.
- 02Write your stories.
